Clinical Trial Update: N-Acetyl-L-Leucine for Ataxia-Telangiectasia (A-T) [Phase 2]

View source ↗

Summary

A Phase 2 study of N-acetyl-L-leucine for Ataxia-Telangiectasia was terminated, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ataxia-telangiectasia

Drugs mentioned

• N-Acetyl-L-Leucine (N-acetyl-L-leucine)

Snippet

Sponsor: IntraBio Inc | Conditions: Ataxia Telangiectasia | Phase 2 | Status: TERMINATED | Results posted: 2026-03-25